BCS Stock Recent News

Barclays PLC (LSE:BARC) announced a further £1 billion share buyback and nudged its interim dividend up 3.5% as profits came in higher than expected despite a decline in investment banking fees compared to last year.  The FTSE 100-listed lender reported a 14% rise in income to £7.2 billion for the second quarter of 2025, with Barclays UK up 12%, UK Corporate up 17%, Barclays Investment Bank up 10% and US Consumer flat.

Investors have been watching the performance of the lender's sharpened investment banking unit, which posted income of £3.3 billion the three months to June.

Barclays first half profit rose by a better than expected 23%, the British bank said on Tuesday, with its markets business reaping bumper returns from the frenzied trading activity unleashed by U.S. President Donald Trump's trade tariffs.

BCS prepares for Q2 results, with gain forecasts in IB, trading and NII, plus updates on its payments partnership.

Graham All Star Value (GASV) strategy identifies top dividend 'dogs' offering high yield and fair pricing, using YCharts' large cap value and Ben Graham screens. Analyst projections suggest the top ten GASV stocks could deliver average net gains of 27.55% by July 2026, with moderate risk. Sixteen of the twenty-one lowest-priced, 'safer' GASV dividend stocks are currently buyable, with dividends exceeding share price for ideal picks.

Right now it's the retail investors that are in control. That's the conclusion from strategists across Wall Street.

NEW YORK--(BUSINESS WIRE)--Barclays today announced the appointment of Alex Ham as Global Chairman of Investment Banking, based in London. Mr. Ham is a proven leader who brings 20 years of experience and leadership to Barclays. He joins from Deutsche Bank where he served as Co-CEO Deutsche Numis and Head of Global Private Growth Capital. In growing that franchise, Mr. Ham developed strong connectivity between European founders of high-growth companies and the leading global venture capitalists,.

Barclays has appointed former Deutsche Bank executive Alex Ham as global chairman of investment banking, the British lender said on Wednesday.

Venu Krishna, Barclays head of U.S. equity strategy, joins CNBC's 'Squawk on the Street' to discuss expectations for how tariffs could impact earnings, market outlooks, and more.

I rate Oscar Health as a buy, viewing short-term regulatory headwinds as a buying opportunity given its long-term growth prospects. Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook, despite recent bearish analyst coverage. The company's strategic expansion into the ICHRA market and deployment of AI technology are key drivers for future revenue and cost efficiency.